Advent Pharma Ltd. (DSE:ADVENT)
Bangladesh · Delayed Price · Currency is BDT 15.40
-0.10 (-0.65%)
At close: Jun 15, 2026
Advent Pharma Market Cap
Advent Pharma has a market cap or net worth of 1.41 billion as of June 16, 2026. Its market cap has increased by 2.72% in one year.
Market Cap
1.41B
Enterprise Value
1.48B
Revenue
458.15M
Ranking
n/a
PE Ratio
29.10
Stock Price
15.40
Market Cap Chart
Since April 12, 2018, Advent Pharma's market cap has decreased from 3.32B to 1.41B, a decrease of -57.64%. That is a compound annual growth rate of -9.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 1.43B | 15.79% |
| Dec 30, 2025 | 1.24B | -20.36% |
| Dec 30, 2024 | 1.56B | -32.93% |
| Dec 28, 2023 | 2.32B | -1.97% |
| Dec 29, 2022 | 2.37B | -0.74% |
| Dec 30, 2021 | 2.38B | 14.47% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Apr 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| The IBN SINA Pharmaceutical Industry | 9.80B |
| Navana Pharmaceuticals | 7.76B |
| Orion Pharma | 6.76B |
| Techno Drugs | 5.85B |
| Silco Pharmaceuticals | 2.16B |
| Indo-Bangla Pharmaceuticals | 1.84B |
| Ambee Pharmaceuticals | 1.83B |
| Silva Pharmaceuticals | 1.80B |